NCT01613703View on ClinicalTrials.gov

ONO-2952 Single-dose PET Study in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

March 31, 2013

Conditions
Healthy Adult Subjects
Interventions
DRUG

ONO-2952

1 mg to 200 mg QD at a single descending dose

Trial Locations (1)

15218

Pittsburgh Clinical Site, Pittsburgh

Sponsors

Lead Sponsor

Ono Pharma USA Inc
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Ono Pharma USA Inc

INDUSTRY